COVID-19: An Emerging Threat to Antibiotic Stewardship in the Emergency Department by Michael S. Pulia, Ian Wolf, Lucas T. Schulz, Aurora Pop-Vicas, Rebecca J. Schwei, Peter K. Lindenauer

Get full text

Clinical Outcomes and Economic Impact of Oritavancin for Gram-Positive Infections: A Single Academic Medical Center Health System Experience by Lauren E. Brownell, Meagan L. Adamsick, Erin K. McCreary, Joshua P. Vanderloo, Erika J. Ernst, Emily R. Jackson, Lucas T Schulz

Get full text

β-Lactam Therapeutic Drug Monitoring in Critically Ill Patients: Weighing the Challenges and Opportunities to Assess Clinical Value by Thomas J. Dilworth, PharmD, Lucas T. Schulz, PharmD, Scott T. Micek, PharmD, Marin H. Kollef, MD, Warren E. Rose, PharmD

Get full text

A geospatial approach to identify patterns of antibiotic susceptibility at a neighborhood level in Wisconsin, United States by Laurel Legenza, Kyle McNair, Song Gao, James P. Lacy, Brooke J. Olson, Thomas R. Fritsche, Lucas T. Schulz, Samantha LaMuro, Frances Spray-Larson, Tahmeena Siddiqui, Warren E. Rose

Get full text

The impact of coronavirus disease 2019 (COVID-19) on the antimicrobial stewardship pharmacist workforce: A multicenter survey by Megan R. Wimmer, Lucas T. Schulz, Ashlee G. Hamel, Rebecca J. Schwei, Karen Fong, Donna R. Burgess, Meghan Brett, Cory M. Hale, Marisa Holubar, Rupali Jain, Rachel Larry, Emily S. Spivak, Helen Newland, Jessica Njoku, Michael Postelnick, Carla Walraven, Michael S. Pulia

Get full text